Log in

Preveceutical Medical Stock Price, News & Analysis (OTCMKTS:PRVCF)

0.00 (0.00 %)
(As of 10/18/2019 04:00 PM ET)
Today's Range
Now: $0.02
50-Day Range
MA: $0.02
52-Week Range
Now: $0.02
Volume2,000 shs
Average Volume62,857 shs
Market Capitalization$8.52 million
P/E RatioN/A
Dividend YieldN/A
PreveCeutical Medical Inc., a health sciences company, develops options for preventive and curative therapies utilizing organic and nature identical products. It has research and development programs, including dual gene therapy for curative and prevention therapies for diabetes and obesity; the Program; Nature Identical peptides for treatment of various ailments; non-addictive analgesic peptides as a replacement to the addictive analgesics, such as morphine, fentanyl, and oxycodone; and a therapeutic product for treating athletes who suffer from concussions. The company offers CELLB9 immune system booster, an oral solution containing polarized and potentiated essential minerals extracted from a peptide obtained from Caribbean blue scorpion venom. It also provides medicinal cannabis-based products. The company has a research and option agreement with University of Queensland; and the UniQuest Pty Limited to develop non-addictive analgesics for the treatment of pain. It also has a strategic research and development supply agreement with Aurora Cannabis to produce medical cannabis. PreveCeutical Medical Inc. is based in Vancouver, Canada.

Industry, Sector and Symbol

Industry Private households



Sales & Book Value

Annual Sales$20,000.00


Net Income$-9,100,000.00
Net Margins-176,516.66%


Market Cap$8.52 million
Next Earnings DateN/A
OptionableNot Optionable

Receive PRVCF News and Ratings via Email

Sign-up to receive the latest news and ratings for PRVCF and its competitors with MarketBeat's FREE daily newsletter.

Preveceutical Medical (OTCMKTS:PRVCF) Frequently Asked Questions

What is Preveceutical Medical's stock symbol?

Preveceutical Medical trades on the OTCMKTS under the ticker symbol "PRVCF."

Has Preveceutical Medical been receiving favorable news coverage?

News coverage about PRVCF stock has trended somewhat positive on Saturday, InfoTrie reports. The research firm rates the sentiment of news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Preveceutical Medical earned a coverage optimism score of 0.8 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View News Stories for Preveceutical Medical.

Who are some of Preveceutical Medical's key competitors?

What other stocks do shareholders of Preveceutical Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Preveceutical Medical investors own include Quantum (QTM), Canarc Resource (CCM), Canopy Growth (CGC), Golden Minerals (AUMN), Molori Energy (MOLOF), Adobe (ADBE), Akoustis Technologies (AKTS), Advanced Micro Devices (AMD), Arrowhead Pharmaceuticals (ARWR) and AXT (AXTI).

Who are Preveceutical Medical's key executives?

Preveceutical Medical's management team includes the folowing people:
  • Mr. Stephen Van Deventer, Chairman & CEO (Age 50)
  • Dr. Makarand Jawadekar Ph.D., Chief Science Officer, Pres & Director (Age 68)
  • Ms. Shabira Rajan CPA, CGA, CFO & Controller (Age 63)
  • Ms. Deanna Kress, Director of Corp. Communications & Investor Relations
  • Ms. Alicia Rebman, Marketing Director (Age 42)

How do I buy shares of Preveceutical Medical?

Shares of PRVCF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Preveceutical Medical's stock price today?

One share of PRVCF stock can currently be purchased for approximately $0.02.

How big of a company is Preveceutical Medical?

Preveceutical Medical has a market capitalization of $8.52 million and generates $20,000.00 in revenue each year. View Additional Information About Preveceutical Medical.

What is Preveceutical Medical's official website?

The official website for Preveceutical Medical is http://www.preveceutical.com/.

How can I contact Preveceutical Medical?

Preveceutical Medical's mailing address is 1177 West Hastings Street Suite 2200, Vancouver A1, V6E 2K3. The company can be reached via phone at 604-416-7777 or via email at [email protected]

MarketBeat Community Rating for Preveceutical Medical (OTCMKTS PRVCF)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  17 (Vote Outperform)
Underperform Votes:  11 (Vote Underperform)
Total Votes:  28
MarketBeat's community ratings are surveys of what our community members think about Preveceutical Medical and other stocks. Vote "Outperform" if you believe PRVCF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PRVCF will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/19/2019 by MarketBeat.com Staff

Featured Article: Economic Reports

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel